Advertisement

Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery

      Data on myocardial infarction (MI) treatment in patients with previous coronary artery bypass grafting (CABG) is limited. We queried the Nationwide Readmissions Database to identify hospitalizations of patients with MI from 2016 to 2019. Among hospitalized patients presenting with MI, 10.3% had previous CABG. Patients with MI who had previous CABG were less likely to be revascularized than those without previous CABG for both ST-segment elevation MI (STEMI) (46.4% vs 68.4%) and non-ST-segment elevation MI (NSTEMI) (30.8% vs 36.7%). CABG was associated with a lower risk of death in NSTEMI patients (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.82 to 0.86), but a higher risk in STEMI patients (OR 1.06, 95% CI 1.01 to 1.13). Revascularization was associated with a lower risk of in-hospital death in patients with previous CABG presenting with STEMI (OR 0.30, 95% CI 0.26 to 0.35) and NSTEMI (OR 0.21, 95% CI 0.19 to 0.23).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Serruys PW
        • Morice MC
        • Kappetein AP
        • Colombo A
        • Holmes DR
        • Mack MJ
        • Ståhle E
        • Feldman TE
        • van den Brand M
        • Bass EJ
        • Van Dyck N
        • Leadley K
        • Dawkins KD
        • Mohr FW
        SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
        N Engl J Med. 2009; 360: 961-972
        • Farkouh ME
        • Domanski M
        • Sleeper LA
        • Siami FS
        • Dangas G
        • Mack M
        • Yang M
        • Cohen DJ
        • Rosenberg Y
        • Solomon SD
        • Desai AS
        • Gersh BJ
        • Magnuson EA
        • Lansky A
        • Boineau R
        • Weinberger J
        • Ramanathan K
        • Sousa JE
        • Rankin J
        • Bhargava B
        • Buse J
        • Hueb W
        • Smith CR
        • Muratov V
        • Bansilal S
        • King III, S
        • Bertrand M
        • Fuster V
        FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes.
        N Engl J Med. 2012; 367: 2375-2384
        • Sabatine MS
        • Bergmark BA
        • Murphy SA
        • O'Gara PT
        • Smith PK
        • Serruys PW
        • Kappetein AP
        • Park SJ
        • Park DW
        • Christiansen EH
        • Holm NR
        • Neilsen PH
        • Stone GW
        • Sabik JF
        • Braunwald E
        Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis [published correction appears in Lancet 2022;399:1606].
        Lancet. 2021; 398: 2247-2257
        • Park SJ
        • Ahn JM
        • Kim YH
        • Park DW
        • Yun SC
        • Lee JY
        • Kang SJ
        • Lee SW
        • Lee CW
        • Park SW
        • Choo SJ
        • Chung CH
        • Lee JW
        • Cohen DJ
        • Yeung AC
        • Hur SH
        • Seung KB
        • Ahn TH
        • Kwon HM
        • Lim DS
        • Rha SW
        • Jeong MH
        • Lee BK
        • Tresukosol D
        • Fu GS
        • Ong TK
        BEST Trial Investigators. Trial of everolimus-eluting stents or bypass surgery for coronary disease.
        N Engl J Med. 2015; 372: 1204-1212
        • Pereg D
        • Fefer P
        • Samuel M
        • Wolff R
        • Czarnecki A
        • Deb S
        • Sparkes JD
        • Fremes SE
        • Strauss BH.
        Native coronary artery patency after coronary artery bypass surgery.
        JACC Cardiovasc Interv. 2014; 7: 761-767
        • Lamy A
        • Eikelboom J
        • Sheth T
        • Connolly S
        • Bosch J
        • Fox KAA
        • Zhu J
        • Lonn E
        • Dagenais G
        • Widimsky P
        • Branch KRH
        • Bhatt DL
        • Zheng Z
        • Straka Z
        • Dagenais F
        • Kong Y
        • Marsden T
        • Lee SF
        • Copland I
        • Yusuf S.
        Rivaroxaban, aspirin, or both to prevent early coronary bypass graft occlusion: the COMPASS-CABG study.
        J Am Coll Cardiol. 2019; 73: 121-130
        • Henderson RA
        • Pocock SJ
        • Sharp SJ
        • Nanchahal K
        • Sculpher MJ
        • Buxton MJ
        • Hampton JR.
        Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting.
        Lancet. 1998; 352: 1419-1425
        • Risum O
        • Abdelnoor M
        • Svennevig JL
        • Levorstad K
        • Nitter-Hauge S.
        Risk factors of recurrent angina pectoris and of non-fatal myocardial infarction after coronary artery bypass surgery.
        Eur J Cardiothorac Surg. 1996; 10: 173-178
        • Campbell PG
        • Teo KSL
        • Worthley SG
        • Kearney MT
        • Tarique A
        • Natarajan A
        • Zaman AG.
        Non-invasive assessment of saphenous vein graft patency in asymptomatic patients.
        Br J Radiol. 2009; 82: 291-295
        • Goldman S
        • Zadina K
        • Moritz T
        • Ovitt T
        • Sethi G
        • Copeland JG
        • Thottapurathu L
        • Krasnicka B
        • Ellis N
        • Anderson RJ
        • Henderson W
        VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study.
        J Am Coll Cardiol. 2004; 44: 2149-2156
        • Khorsandi M
        • Dougherty S
        • Bouamra O
        • Pai V
        • Curry P
        • Tsui S
        • Clark S
        • Westaby S
        • Al-Attar N
        • Zamvar V.
        Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis.
        J Cardiothorac Surg. 2017; 12: 55
        • Elbadawi A
        • Elzeneini M
        • Elgendy IY
        • Megaly M
        • Omer M
        • Jimenez E
        • Ghanta RK
        • Brilakis ES
        • Jneid H.
        Coronary artery bypass grafting after acute ST-elevation myocardial infarction [published online March 31,.2021].
        J Thorac Cardiovasc Surg. 2021; https://doi.org/10.1016/j.jtcvs.2021.03.081
        • Elbadawi A
        • Hamed M
        • Elgendy IY
        • Omer MA
        • Ogunbayo GO
        • Megaly M
        • Denktas A
        • Ghanta R
        • Jimenez E
        • Brilakis E
        • Jneid H.
        Outcomes of reoperative coronary artery bypass graft surgery in the United States.
        J Am Heart Assoc. 2020; 9e016282
        • Khera R
        • Angraal S
        • Couch T
        • Welsh JW
        • Nallamothu BK
        • Girotra S
        • Chan PS
        • Krumholz HM.
        Adherence to methodological standards in research using the National Inpatient Sample.
        JAMA. 2017; 318: 2011-2018
        • Houchens R
        • Ross D
        • Elixhauser A.
        Using the HCUP National Inpatient Sample to estimate trends.
        HCUP methods series report # 2006-05. U.S. Agency for Healthcare Research and Quality, 2015 (Available at)
        • Kytö V
        • Sipilä J
        • Rautava P.
        Association of age and gender with risk for non-ST-elevation myocardial infarction.
        Eur J Prev Cardiol. 2015; 22: 1003-1008
        • Redfors B
        • Généreux P
        • Witzenbichler B
        • McAndrew T
        • Diamond J
        • Huang X
        • Maehara A
        • Weisz G
        • Mehran R
        • Kirtane AJ
        • Stone GW.
        Percutaneous coronary intervention of saphenous vein graft.
        Circ Cardiovasc Interv. 2017; 10e004953
        • Xenogiannis I
        • Zenati M
        • Bhatt DL
        • Rao SV
        • Rodés-Cabau J
        • Goldman S
        • Shunk KA
        • Mavromatis K
        • Banerjee S
        • Alaswad K
        • Nikolakopoulos I
        • Vemmou E
        • Karacsonyi J
        • Alexopoulos D
        • Burke MN
        • Bapat VN
        • Brilakis ES.
        Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies.
        Circulation. 2021; 144: 728-745
        • Fefer P
        • Knudtson ML
        • Cheema AN
        • Galbraith PD
        • Osherov AB
        • Yalonetsky S
        • Gannot S
        • Samuel M
        • Weisbrod M
        • Bierstone D
        • Sparkes JD
        • Wright GA
        • Strauss BH.
        Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.
        J Am Coll Cardiol. 2012; 59: 991-997
        • Shoaib A
        • Rashid M
        • Berry C
        • Curzen N
        • Kontopantelis E
        • Timmis A
        • Ahmad A
        • Kinnaird T
        • Mamas MA.
        Clinical characteristics, management strategies, and outcomes of non–ST-segment–elevation myocardial infarction patients with and without prior coronary artery bypass grafting.
        J Am Heart Assoc. 2021; 10e018823
        • Welsh RC
        • Granger CB
        • Westerhout CM
        • Blankenship JC
        • Holmes Jr, DR
        • O'Neill WW
        • Hamm CW
        • Van de Werf F
        • Armstrong PW
        APEX AMI Investigators. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
        JACC Cardiovasc Intv. 2010; 3: 343-351
        • Alkhouli M
        • Alqahtani F
        • Kalra A
        • Gafoor S
        • Alhajji M
        • Alreshidan M
        • Holmes DR
        • Lerman A.
        Trends in characteristics and outcomes of hospital inpatients undergoing coronary revascularization in the United States, 2003–2016.
        JAMA Netw Open. 2020; 3e1921326
        • Tegn N
        • Abdelnoor M
        • Aaberge L
        • Endresen K
        • Smith P
        • Aakhus S
        • Gjertsen E
        • Dahl-Hofseth O
        • Ranhoff AH
        • Gullestad L
        • Bendz B
        After Eighty study investigators. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
        Lancet. 2016; 387: 1057-1065